Seminars in Nephrology
Volume 29, Issue 1 , Pages 67-74 , January 2009

Correction of Metabolic Acidosis to Ameliorate Wasting in Chronic Kidney Disease: Goals and Strategies

  • Yi-Wen Chiu, MD

      Affiliations

    • Division of Nephrology, Department of Internal Medicine, at Kaohsiung Medical University Hospital, Kaohsiung, Taiwan
    • ,
  • Joel D. Kopple, MD

      Affiliations

    • Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, CA
    • David Geffen School of Medicine at UCLA, Los Angeles, CA
    • UCLA School of Public Health, Los Angles, CA
    • ,
  • Rajnish Mehrotra, MD

      Affiliations

    • Division of Nephrology and Hypertension, Los Angeles Biomedical Research Institute at Harbor-UCLA Medical Center, Los Angeles, CA
    • David Geffen School of Medicine at UCLA, Los Angeles, CA
    • Corresponding Author InformationAddress reprint requests to Rajnish Mehrotra, MD, Division of Nephrology and Hypertension, Harbor-UCLA Medical Center, 1124 W. Carson St, Torrance, CA 90509

References 

  1. Mehrotra R, Kopple JD, Wolfson M. Metabolic acidosis in maintenance dialysis patients: clinical considerations. Kidney Int Suppl. 2003;88:S13–S25
  2. Kalantar-Zadeh K, Mehrotra R, Fouque D, et al. Metabolic acidosis and malnutrition-inflammation complex syndrome in chronic renal failure. Semin Dial. 2004;17:455–465
  3. Kopple JD, Kalantar-Zadeh K, Mehrotra R. Risks of chronic metabolic acidosis in patients with chronic kidney disease. Kidney Int Suppl. 2005;95:S21–S27
  4. Lowrie EG, Lew NL. Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities. Am J Kidney Dis. 1990;15:458–482
  5. Bommer J, Locatelli F, Satayathum S, et al. Association of predialysis serum bicarbonate levels with risk of mortality and hospitalization in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis. 2004;44:661–671
  6. Wu DY, Shinaberger CS, Regidor DL, et al. Association between serum bicarbonate and death in hemodialysis patients: is it better to be acidotic or alkalotic?. Clin J Am Soc Nephrol. 2006;1:70–78
  7. K/DOQI, National Kidney Foundation. Clinical practice guidelines for nutrition in chronic renal failure. Am J Kidney Dis. 2000;35(Suppl 2):S1–S140
  8. National Kidney Foundation. K/DOQI clinical practice guidelines for bone metabolism and disease in chronic kidney disease. Am J Kidney Dis. 2003;42(Suppl 3):S1–S201
  9. Herr RD, Swanson T. Serum bicarbonate declines with sample size in vacutainer tubes. Am J Clin Pathol. 1992;97:213–216
  10. Laski ME. Penny wise and bicarbonate foolish. Am J Kidney Dis. 2000;35:1224–1225
  11. Brezina B, Qunibi WY, Nolan CR. Acid loading during treatment with sevelamer hydrochloride: mechanisms and clinical implications. Kidney Int Suppl. 2004;90:S39–S45
  12. Borras M, Marco MP, Fernandez E. Treatment with sevelamer decreases bicarbonate levels in peritoneal dialysis patients. Perit Dial Int. 2002;22:737–738
  13. Marco MP, Muray S, Betriu A, et al. Treatment with sevelamer decreases bicarbonate levels in hemodialysis patients. Nephron. 2002;92:499–500
  14. Fouque D, lantar-Zadeh K, Kopple J, et al. A proposed nomenclature and diagnostic criteria for protein-energy wasting in acute and chronic kidney disease. Kidney Int. 2008;73:391–398
  15. May RC, Kelly RA, Mitch WE. Metabolic acidosis stimulates protein degradation in rat muscle by a glucocorticoid-dependent mechanism. J Clin Invest. 1986;77:614–621
  16. Hara Y, May RC, Kelly RA, et al. Acidosis, not azotemia, stimulates branched-chain, amino acid catabolism in uremic rats. Kidney Int. 1987;32:808–814
  17. May RC, Hara Y, Kelly RA, et al. Branched-chain amino acid metabolism in rat muscle: abnormal regulation in acidosis. Am J Physiol. 1987;252:E712–E718
  18. May RC, Kelly RA, Mitch WE. Mechanisms for defects in muscle protein metabolism in rats with chronic uremia (Influence of metabolic acidosis). J Clin Invest. 1987;79:1099–1103
  19. Bailey JL, Wang X, England BK, et al. The acidosis of chronic renal failure activates muscle proteolysis in rats by augmenting transcription of genes encoding proteins of the ATP-dependent ubiquitin-proteasome pathway. J Clin Invest. 1996;97:1447–1453
  20. Mitch WE, Medina R, Grieber S, et al. Metabolic acidosis stimulates muscle protein degradation by activating the adenosine triphosphate-dependent pathway involving ubiquitin and proteasomes. J Clin Invest. 1994;93:2127–2133
  21. Du J, Wang X, Miereles C, et al. Activation of caspase-3 is an initial step triggering accelerated muscle proteolysis in catabolic conditions. J Clin Invest. 2004;113:115–123
  22. Bailey JL, Zheng B, Hu Z, et al. Chronic kidney disease causes defects in signaling through the insulin receptor substrate/phosphatidylinositol 3-kinase/Akt pathway: implications for muscle atrophy. J Am Soc Nephrol. 2006;17:1388–1394
  23. Price SR, England BK, Bailey JL, et al. Acidosis and glucocorticoids concomitantly increase ubiquitin and proteasome subunit mRNAs in rat muscle. Am J Physiol. 1994;267:C955–C960
  24. Mitch WE, Bailey JL, Wang X, et al. Evaluation of signals activating ubiquitin-proteasome proteolysis in a model of muscle wasting. Am J Physiol Cell Physiol. 1999;276:C1132–C1138
  25. Cano NJ, Fouque D, Leverve XM. Application of branched-chain amino acids in human pathological states: renal failure. J Nutr. 2006;136(suppl 1):299S–307S
  26. England BK, Greiber S, Mitch WE, et al. Rat muscle branched-chain ketoacid dehydrogenase activity and mRNAs increase with extracellular acidemia. Am J Physiol. 1995;268:C1395–C1400
  27. Lofberg E, Gutierrez A, Anderstam B, et al. Effect of bicarbonate on muscle protein in patients receiving hemodialysis. Am J Kidney Dis. 2006;48:419–429
  28. Lofberg E, Wernerman J, Anderstam B, et al. Correction of acidosis in dialysis patients increases branched-chain and total essential amino acid levels in muscle. Clin Nephrol. 1997;48:230–237
  29. Bevington A, Poulter C, Brown J, et al. Inhibition of protein synthesis by acid in L6 skeletal muscle cells: analogies with the acute starvation response. Miner Electrolyte Metab. 1998;24:261–266
  30. Ulrich C, Kruger B, Kohler H, et al. Effects of acidosis on acute phase protein metabolism in liver cells. Miner Electrolyte Metab. 1999;25:228–233
  31. Papadoyannakis NJ, Stefanidis CJ, McGeown M. The effect of the correction of metabolic acidosis on nitrogen and potassium balance of patients with chronic renal failure. Am J Clin Nutr. 1984;40:623–627
  32. Reaich D, Channon SM, Scrimgeour CM, et al. Correction of acidosis in humans with CRF decreases protein degradation and amino acid oxidation. Am J Physiol. 1993;265:E230–E235
  33. Williams B, Hattersley J, Lawyard E, et al. Metabolic acidosis and skeletal muscle adaptation to low protein diets in chronic uremia. Kidney Int. 1991;40:779–786
  34. Garibotto G, Russo R, Sofia A, et al. Skeletal muscle protein synthesis and degradation in patients with chronic renal failure. Kidney Int. 1994;45:1432–1439
  35. Graham KA, Reaich D, Channon SM, et al. Correction of acidosis in CAPD decreases whole body protein degradation. Kidney Int. 1996;49:1396–1400
  36. Graham KA, Reaich D, Channon SM, et al. Correction of acidosis in hemodialysis decreases whole-body protein degradation. J Am Soc Nephrol. 1997;8:632–637
  37. Lim VS, Yarasheski KE, Flanigan MJ. The effect of uraemia, acidosis, and dialysis treatment on protein metabolism: a longitudinal leucine kinetic study. Nephrol Dial Transplant. 1998;13:1723–1730
  38. Boirie Y, Broyer M, Gagnadoux MF, et al. Alterations of protein metabolism by metabolic acidosis in children with chronic renal failure. Kidney Int. 2000;58:236–241
  39. Uribarri J, Levin NW, Delmez J, et al. Association of acidosis and nutritional parameters in hemodialysis patients. Am J Kidney Dis. 1999;34:493–499
  40. Leavey SF, Strawderman RL, Young EW, et al. Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients. Kidney Int. 2000;58:2119–2128
  41. Chauveau P, Fouque D, Combe C, et al. Acidosis and nutritional status in hemodialyzed patients (French Study Group for Nutrition in Dialysis). Semin Dial. 2000;13:241–246
  42. Gennari FJ, Hood VL, Greene T, et al. Effect of dietary protein intake on serum total CO2 concentration in chronic kidney disease: Modification of Diet in Renal Disease study findings. Clin J Am Soc Nephrol. 2006;1:52–57
  43. Dunloup DM, Stewart CP. The alkaline treatment of chronic nephritis. DD Lancet. 1931;2:1009–1013
  44. Seyffart G, Ensminger A, Scholz R. Increase of body mass during long-term bicarbonate hemodialysis. Kidney Int Suppl. 1987;22:S174–S177
  45. Kooman JP, Deutz NE, Zijlmans P, et al. The influence of bicarbonate supplementation on plasma levels of branched-chain amino acids in haemodialysis patients with metabolic acidosis. Nephrol Dial Transplant. 1997;12:2397–2401
  46. Movilli E, Zani R, Carli O, et al. Correction of metabolic acidosis increases serum albumin concentrations and decreases kinetically evaluated protein intake in haemodialysis patients: a prospective study. Nephrol Dial Transplant. 1998;13:1719–1722
  47. Lin SH, Lin YF, Chin HM, et al. Must metabolic acidosis be associated with malnutrition in haemodialysed patients?. Nephrol Dial Transplant. 2002;17:2006–2010
  48. Verove C, Maisonneuve N, El Azouzi A, et al. Effect of the correction of metabolic acidosis on nutritional status in elderly patients with chronic renal failure. J Ren Nutr. 2002;12:224–228
  49. Blair D, Bigelow C, Sweet SJ. Nutritional effects of delivered bicarbonate dose in maintenance hemodialysis patients. J Ren Nutr. 2003;13:205–211
  50. Bossola M, Giungi S, Tazza L, et al. Long-term oral sodium bicarbonate supplementation does not improve serum albumin levels in hemodialysis patients. Nephron Clin Pract. 2007;106:c51–c56
  51. Williams AJ, Dittmer ID, McArley A, et al. High bicarbonate dialysate in haemodialysis patients: effects on acidosis and nutritional status. Nephrol Dial Transplant. 1997;12:2633–2637
  52. Brady JP, Hasbargen JA. Correction of metabolic acidosis and its effect on albumin in chronic hemodialysis patients. Am J Kidney Dis. 1998;31:35–40
  53. Stein A, Moorhouse J, Iles-Smith H, et al. Role of an improvement in acid-base status and nutrition in CAPD patients. Kidney Int. 1997;52:1089–1095
  54. Szeto CC, Wong TY, Chow KM, et al. Oral sodium bicarbonate for the treatment of metabolic acidosis in peritoneal dialysis patients: a randomized placebo-control trial. J Am Soc Nephrol. 2003;14:2119–2126
  55. Feriani M, Passlick-Deetjen J, Jaeckle-Meyer I, et al. Individualized bicarbonate concentrations in the peritoneal dialysis fluid to optimize acid-base status in CAPD patients. Nephrol Dial Transplant. 2004;19:195–202
  56. Roderick P, Willis NS, Blakeley S, et al. Correction of chronic metabolic acidosis for chronic kidney disease patients. Cochrane Database Syst Rev. 2007;1:CD001890
  57. Uribarri J. How should dialysis fluid be individualized for the chronic hemodialysis patient?. Bicarbonate. Semin Dial. 2008;21:221–223

 Rajnish Mehrotra is supported by grants from the National Institutes of Health (RR18298), Satellite Health, and DaVita, Inc.; and has received research support from Amgen, Baxter Health Care, and Shire, honoraria from Baxter Health Care and Shire, and has served as a consultant for Novartis.

PII: S0270-9295(08)00172-1

doi: 10.1016/j.semnephrol.2008.10.009

Seminars in Nephrology
Volume 29, Issue 1 , Pages 67-74 , January 2009

Article Tools

* Image Usage & Resolution